Updates on adjuvant chemotherapy and radiation therapy for endometrial cancer-Reference-Cited by-同舟云学术

Updates on adjuvant chemotherapy and radiation therapy for endometrial cancer

Published:2019-02 Issue:1 Volume:31 Page:31-37
ISSN:1040-872X
Container-title:Current Opinion in Obstetrics & Gynecology
language:en
Short-container-title:

Author:

Cowan Matthew,Strauss Jonathan B.,Barber Emma L.,Matei Daniela

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Obstetrics and Gynecology

Reference31 articles.

1. Cancer statistics, 2018;Siegel;CA: a cancer journal for clinicians,2018

2. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients;Aalders;Obstet Gynecol,1980

3. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial;Creutzberg;Lancet,2000

4. Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma;Creutzberg;Int J Radiat Oncol Biol Phys,2011

5. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial;Nout;J Clin Oncol,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer;International Journal of Environmental Research and Public Health;2023-02-16

2. Targeting the NRF2/KEAP1 pathway in cervical and endometrial cancers;European Journal of Pharmacology;2023-02

3. Endometrial carcinosarcoma: a poor prognosis debut with favourable therapeutic outcome;ecancermedicalscience;2022-11-17

4. Evaluation of the efficiency and safety of adjuvant chemotherapy alone for patients with advanced endometrial carcinoma: A protocol for systematic review and meta-analysis;Medicine;2022-07-15

5. Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study;Gynecologic Oncology;2022-02